跳至主要内容
临床试验/NCT02680314
NCT02680314已完成2 期

Is More Than One Dose of Misoprostol Needed to Expedite Vaginal Delivery in a Patient With an Unripe Cervix?

Montefiore Medical Center0 个研究点目标入组 243 人开始时间: 2016年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
243
主要终点
Number of Participants With Vaginal Delivery Within 24 Hours

研究概览

简要总结

The goal of this study is to determine whether inducing labor with just one dose of misoprostol, followed by treatment with oxytocin, will still be effective enough to increase the chances of having a successful vaginal delivery as compared to using more than one dose of misoprostol, followed by treatment with oxytocin.

详细描述

This study involves a comparison of two different regimens of prostaglandin use for "cervical ripening" prior to induction of labor. Women admitted to the hospital for induction of labor who are found to have "unripe" cervixes at the time of admission, and who agree to participate in the study will be randomly assigned to one of two treatment groups. In one group, a single dose of 25 µcg of misoprostol will be administered vaginally and four hours later oxytocin induction will be started if clinically indicated. In the second group of women, repeat doses of misoprostol will be given every four hours up to six doses unless labor or cervical ripening occurs sooner. At this point, oxytocin will be started as needed. Success of vaginal delivery by 24 hours, time from initiation of protocol to delivery and cesarean section rates will be compared. Complications such as postpartum hemorrhage, episodes of tachysystole with fetal compromise and chorioamnionitis and endometritis will be monitored.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Any pregnant woman undergoing induction of labor
  • Live singleton pregnancy ≥ 37 week gestation
  • Bishop score < 6
  • Category I fetal heart rate

排除标准

  • Contraindications to vaginal delivery (e.g. vasa previa, placenta prevue,non-vertex presentation, umbilical cord prolapse, and active genital herpes infection.)
  • Pregnancies complicated by major fetal anomalies
  • Any contraindication to the use of misoprostol, including
  • History of previous c-section or major uterine surgery
  • Prior allergic reaction
  • Category II or III fetal heart rate
  • Regular uterine contractions ≥ 3 in a 10-minute period persistent for at least 30 minutes
  • Estimated fetal weight < 10 percentile
  • Premature rupture of membranes
  • Age < 18 years old
  • Women who do not have the capacity to consent

研究组 & 干预措施

Single Dose

Active Comparator

single dose of misoprostol

干预措施: Misoprostol (Drug)

Multiple Dose

Active Comparator

multiple doses of misoprostol

干预措施: Misoprostol (Drug)

结局指标

主要结局

Number of Participants With Vaginal Delivery Within 24 Hours

时间窗: within 24 hours

To compare the rate of vaginal delivery within 24 hours in patients who receive a single dose of misoprostol versus those receiving multiple doses of this medication.

次要结局

  • To Determine the Interval From Initiation of Misoprostol to Delivery in Each Group(within 24 hours from the initial intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Peter S. Bernstein

Prof., Maternal Fetal Medicine

Montefiore Medical Center

相似试验

Is More Than One Dose of Misoprostol Needed to... | 临床试验